Valuation: DHG Pharmaceutical

Market Cap 11,087B 430M 384M 353M 321M 601M 40.75B 613M 4.21B 1.7B 21.51B 1.62B 1.58B 67.94B P/E 2026 *
11.9x
P/E 2027 * 11.3x
Enterprise Value 9,225B 358M 320M 293M 267M 500M 33.91B 510M 3.5B 1.41B 17.9B 1.34B 1.32B 56.53B EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.62x
Free-Float
48.78%
Yield 2026 *
8.25%
Yield 2027 * 8.49%
Oct. 20 DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 CI
Aug. 20 DHG Pharma Announces Final Dividend for 2025, Payable on 30 Sep. 2026 CI
Jul. 20 DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
Jul. 14 Large Enterprise Tax Sub-Department Imposes Administrative Penalty on DHG Pharmaceutical Joint Stock Company CI
May. 24 DHG Pharmaceutical Joint Stock Company Receives the Confirmation Certificate of Registration Changes CI
Apr. 29 DHG Pharmaceutical Joint Stock Company Announces Adjustment of Position of Osamu Fujimori as Deputy General Director in Charge of Finance and Supply Chain, Effective May 1, 2026 CI
Apr. 22 DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for 2026 CI
Apr. 22 DHG Pharmaceutical Joint Stock Company Announces Board Changes, Effective April 21, 2026 CI
Apr. 22 DHG Pharmaceutical Joint Stock Company Approves Dividend for the Fiscal Year Ended December 31, 2025, Payable on 28 May 2026 and in September 2026 CI
Apr. 22 DHG Pharmaceutical Joint Stock Company Provides Dividend Guidance for the Fiscal Year 2026 CI
Apr. 20 DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
Mar. 26 DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2026 CI
Jan. 20 DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
1 day-2.42%
1 week-3.42%
Current month-2.42%
1 month-5.15%
3 months-8.42%
6 months-15.20%
Current year-17.11%
1 week 84,800
Extreme 84800
88,000
1 month 84,800
Extreme 84800
90,500
Current year 84,800
Extreme 84800
109,000
1 year 84,800
Extreme 84800
109,000
3 years 84,800
Extreme 84800
125,900
5 years 78,000
Extreme 78000
142,500
10 years 61,000
Extreme 60999.999999
142,500
Manager TitleAgeSince
Chief Executive Officer 59 -
Director of Finance/CFO - -
Chief Executive Officer 52 2017-08-31
Director TitleAgeSince
Director/Board Member 52 2000-02-29
Director/Board Member 70 2016-08-14
Chairman - 2019-06-10
Date Insider Type Main position Quantity % Market Cap. Importance
5/26/22 Buy

Chief Financial Officer

18,700 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-2.42%-3.42%-19.70%-17.67% 430M
-0.46%+10.31%+63.52%+143.15% 1,257B
-0.97%+1.60%+43.25%+80.09% 651B
-2.05%+0.73%+32.47%+101.62% 510B
-0.08%-0.58%+52.87%+67.21% 388B
-0.78%+5.51%+72.55%+44.25% 366B
+0.75%+2.75%+32.98%+58.77% 303B
+0.14%+8.00%+12.00%+34.84% 288B
-0.12%+4.68%+55.97%+74.59% 252B
-0.21%+7.34%+42.19%+109.69% 211B
Average -0.40%+3.83%+38.81%+69.65% 422.71B
Weighted average by Cap. -0.37%+5.30%+49.23%+93.68%

Financials

2026 *2027 *
Net sales 5,435B 211M 188M 173M 157M 295M 19.98B 301M 2.06B 832M 10.54B 792M 775M 33.3B 5,691B 221M 197M 181M 165M 309M 20.92B 315M 2.16B 871M 11.04B 829M 812M 34.87B
Net income 928B 36.04M 32.18M 29.53M 26.86M 50.36M 3.41B 51.37M 353M 142M 1.8B 135M 132M 5.69B 983B 38.18M 34.09M 31.28M 28.45M 53.35M 3.61B 54.41M 374M 151M 1.91B 143M 140M 6.03B
Net Debt -1,862B -72.31M -64.56M -59.24M -53.89M -101M -6.85B -103M -708M -285M -3.61B -271M -266M -11.41B -1,858B -72.13M -64.4M -59.09M -53.75M -101M -6.83B -103M -706M -285M -3.6B -271M -265M -11.38B
Projected Income Statement - Annual - DHG Pharmaceutical
Logo DHG Pharmaceutical
DHG Pharmaceutical Joint Stock Company is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets pharmaceutical products, vitamins, supplements and cosmetics. Via its subsidiaries, the Company is also involved in packaging printing, herb cultivation, medicinal supplies trading, as well as domestic travel tour and medical clinic operation.
Employees
2,812
Date Price Change Volume
26-11-02 ₫84,800.00 -2.42% 19,861
26-10-30 ₫86,900.00 -0.46% 5,806
26-10-29 ₫87,300.00 0.00% 3,469
26-10-28 ₫87,300.00 -0.23% 4,221
26-10-27 ₫87,500.00 -0.34% 9,610
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - DHG Pharmaceutical
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
84,800.00VND
Average target price
97,600.00VND
Spread / Average Target
+15.09%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - DHG Pharmaceutical